These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 25843662)
1. Novel curcumin-based pyrano[2,3-d]pyrimidine anti-oxidant inhibitors for α-amylase and α-glucosidase: Implications for their pleiotropic effects against diabetes complications. Yousefi A; Yousefi R; Panahi F; Sarikhani S; Zolghadr AR; Bahaoddini A; Khalafi-Nezhad A Int J Biol Macromol; 2015; 78():46-55. PubMed ID: 25843662 [TBL] [Abstract][Full Text] [Related]
2. Curcumin-based Antioxidant and Glycohydrolase Inhibitor Compounds: Synthesis and In Vitro Appraisal of the Dual Activity Against Diabetes. Esmaeili S; Ghobadi N; Nazari D; Pourhossein A; Rasouli H; Adibi H; Khodarahmi R Med Chem; 2021; 17(7):677-698. PubMed ID: 32370719 [TBL] [Abstract][Full Text] [Related]
3. Antioxidant and glycohydrolase inhibitory behavior of curcumin-based compounds: Synthesis and evaluation of anti-diabetic properties in vitro. Mehrabi M; Esmaeili S; Ezati M; Abassi M; Rasouli H; Nazari D; Adibi H; Khodarahmi R Bioorg Chem; 2021 May; 110():104720. PubMed ID: 33662896 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of new curcumin derivatives as influential antidiabetic α-glucosidase and α-amylase inhibitors with anti-oxidant activity. Tavaf Z; Dangolani SK; Yousefi R; Panahi F; Shahsavani MB; Khalafi-Nezhad A Carbohydr Res; 2020 Aug; 494():108069. PubMed ID: 32563890 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, spectroscopic characterizations, antidiabetic, in silico and kinetic evaluation of novel curcumin-fused aldohexoses. Ezati M; Ghavamipour F; Adibi H; Pouraghajan K; Arab SS; Sajedi RH; Khodarahmi R Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121806. PubMed ID: 36108405 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel poly-hydroxyl functionalized acridine derivatives as inhibitors of α-Glucosidase and α-Amylase. Toobaei Z; Yousefi R; Panahi F; Shahidpour S; Nourisefat M; Doroodmand MM; Khalafi-Nezhad A Carbohydr Res; 2015 Jun; 411():22-32. PubMed ID: 25957572 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of β-Ketoamide Curcumin Analogs for Anti-Diabetic and AGEs Inhibitory Activities. Banuppriya G; Sribalan R; Fathima SAR; Padmini V Chem Biodivers; 2018 Aug; 15(8):e1800105. PubMed ID: 29752771 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors. Panahi F; Yousefi R; Mehraban MH; Khalafi-Nezhad A Carbohydr Res; 2013 Oct; 380():81-91. PubMed ID: 23978663 [TBL] [Abstract][Full Text] [Related]
10. Turmeric (Curcuma longa L.) volatile oil inhibits key enzymes linked to type 2 diabetes. Lekshmi PC; Arimboor R; Indulekha PS; Menon AN Int J Food Sci Nutr; 2012 Nov; 63(7):832-4. PubMed ID: 22385048 [TBL] [Abstract][Full Text] [Related]
11. Studies on the potential antioxidant properties of Senecio stabianus Lacaita (Asteraceae) and its inhibitory activity against carbohydrate-hydrolysing enzymes. Tundis R; Menichini F; Loizzo MR; Bonesi M; Solimene U; Menichini F Nat Prod Res; 2012; 26(5):393-404. PubMed ID: 21644170 [TBL] [Abstract][Full Text] [Related]
12. The assessment of antidiabetic properties of novel synthetic curcumin analogues: α-amylase and α-glucosidase as the target enzymes. Hasaninezhad F; Tavaf Z; Panahi F; Nourisefat M; Khalafi-Nezhad A; Yousefi R J Diabetes Metab Disord; 2020 Dec; 19(2):1505-1515. PubMed ID: 33553036 [TBL] [Abstract][Full Text] [Related]
13. Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Lekshmi PC; Arimboor R; Raghu KG; Menon AN Nat Prod Res; 2012; 26(17):1654-8. PubMed ID: 21972920 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Potential Antidiabetic Properties of Curcumin-Based Derivatives: An Ezati M; Ghavamipour F; Khosravi N; Sajedi RH; Chalabi M; Farokhi A; Adibi H; Khodarahmi R Med Chem; 2022; 19(1):99-117. PubMed ID: 35579152 [TBL] [Abstract][Full Text] [Related]
15. Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for α-glucosidase. Yousefi R; Alavian-Mehr MM; Mokhtari F; Panahi F; Mehraban MH; Khalafi-Nezhad A J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1228-35. PubMed ID: 23043430 [TBL] [Abstract][Full Text] [Related]
16. Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs. Du ZY; Liu RR; Shao WY; Mao XP; Ma L; Gu LQ; Huang ZS; Chan AS Eur J Med Chem; 2006 Feb; 41(2):213-8. PubMed ID: 16387392 [TBL] [Abstract][Full Text] [Related]
17. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585 [TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean. McCue P; Kwon YI; Shetty K Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931 [TBL] [Abstract][Full Text] [Related]
19. Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: a virtual screening perspective for the treatment of obesity and diabetes. Rasouli H; Hosseini-Ghazvini SM; Adibi H; Khodarahmi R Food Funct; 2017 May; 8(5):1942-1954. PubMed ID: 28470323 [TBL] [Abstract][Full Text] [Related]
20. Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study. Oboh G; Agunloye OM; Adefegha SA; Akinyemi AJ; Ademiluyi AO J Basic Clin Physiol Pharmacol; 2015 Mar; 26(2):165-70. PubMed ID: 24825096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]